Medical Oncologist
Cardiac effects
Heart Rhythm and Ejection Fraction — Changes on Osimertinib
Osimertinib can affect two aspects of heart function: the electrical rhythm and the pumping strength. Both can change without obvious symptoms, which is why monitoring is built into your treatment schedule.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Two separate effects — Rhythm changes and reduced pumping strength are different problems with different symptoms and different management.
- Often silent at first — Many people have no symptoms when these changes begin, which is why ECGs and heart scans are part of your treatment plan.
- Symptoms to know — Palpitations, new breathlessness, ankle swelling and dizziness are the signs your team wants to hear about promptly.
- Most cases are manageable — Caught early, most heart effects on osimertinib can be managed, sometimes with a dose adjustment or a short treatment pause.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Osimertinib can affect the heart in two ways: it can alter the electrical rhythm, and in some patients it can reduce the heart's pumping strength. Most people do not develop serious problems. Both changes are monitored with ECGs and heart scans because they can worsen without obvious symptoms.
Are heart rhythm and ejection fraction changes on osimertinib dangerous?
Osimertinib can prolong the QT interval — an electrical measure of how the heart resets between beats. For most people taking the drug, this change is small and picked up on a routine ECG rather than felt as a symptom.
In a proportion of patients, the heart muscle can become less efficient at pumping over time. This is called a reduction in ejection fraction, and it can be silent for months before it causes noticeable breathlessness or fatigue.
Neither of these effects is inevitable, and both can be managed when caught early. Your oncology team orders ECGs and heart scans on a schedule specifically to find these changes before they become serious.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What can you do between appointments to protect your heart?
You do not need to take any special action at home. The most important thing is to avoid starting new medicines — including over-the-counter tablets and herbal preparations — without checking with your team first.
Several common drugs can additionally affect heart rhythm on top of osimertinib, and your team needs to know everything you are taking to assess the combined risk.
If you notice mild palpitations — an occasional flutter that lasts a few seconds and then stops — write down when it happened, how long it lasted, and what you were doing. That record helps your team assess it at your next visit rather than relying on your memory.
How do you grade heart symptoms on osimertinib?
| Symptom | Mild — note and tell team at next visit | Needs a same-day call |
|---|---|---|
| Palpitations | Brief flutter lasting a few seconds, settles on its own | Lasts minutes, feels severe, or comes with dizziness or chest tightness |
| Breathlessness | Slightly more breathless than before on stairs or exertion | Breathless at rest, waking you at night, or stopping you mid-sentence |
| Ankle or leg swelling | Mild puffiness that has cleared by morning | Pitting swelling that does not settle, especially alongside breathlessness |
| Dizziness | Brief head-rush on standing, settles within seconds | Persistent, worsens over the day, or nearly causes a fall |
| Typically starts | ECG rhythm changes can appear early in treatment | Reduced pumping strength more often appears after several months |
What should I tell my oncology team at each visit?
- Whether you have noticed palpitations — when they happened, how long they lasted, and whether anything was happening at the time
- Any new breathlessness, particularly at night or on effort that did not trouble you before
- Ankle or leg swelling that is new or has increased since your last visit
- Every medicine, supplement and herbal preparation you are currently taking, including anything bought without a prescription
- Whether you have had an ECG or heart scan done elsewhere since your last oncology visit
- Any family history of heart rhythm problems or sudden cardiac events, if you have not already mentioned it
Explore 75 more Lung Cancer Targeted Medicines topics
Drug Deep Dive: Osimertinib (Tagrisso)
- Adjuvant Osimertinib After Lung Cancer Surgery: Three Years of Tablets
- Breathlessness or New Cough on Osimertinib: Recognising Lung Injury (ILD)
- Diet and Nutrition While on Osimertinib
- Drug, Food and Supplement Interactions With Osimertinib
- Fertility, Pregnancy and Contraception on Osimertinib
- Heart Rhythm and Ejection Fraction Changes on Osimertinib
- How Does Osimertinib Work? The Third-Generation EGFR Inhibitor Explained
- How Long Does Osimertinib Take to Work?
- How Long Will You Stay on Osimertinib?
- Osimertinib (Tagrisso): The Complete Patient Guide
- Osimertinib Myths: Clear Scans, Stopping Early and Generic Quality
- Osimertinib Price in India: Brand, Generic and Monthly Cost
- Osimertinib Side Effects: The Complete List and Timeline
- Osimertinib Success Rate and Survival: An Honest Look at the Numbers
- Osimertinib With Chemotherapy: Who Actually Benefits From the Combination?
- Osimertinib and Brain Metastases: Why It Works Inside the Brain
- Osimertinib in Elderly Patients and Those With Other Illnesses
- Osimertinib vs Gefitinib and Erlotinib: Is the Costlier Drug Worth It?
- Rash, Dry Skin and Nail Problems on Osimertinib
- Taking Osimertinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Osimertinib
- When Osimertinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Osimertinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Osimertinib?
- Work, Travel and Daily Life on Osimertinib
Drug Deep Dive: Alectinib (Alecensa)
- Alectinib (Alecensa, Alectinib): The Complete Patient Guide
- Alectinib After Surgery for Early-Stage ALK-Positive Lung Cancer
- Alectinib Myths: Is ALK-Positive Cancer 'Curable'?
- Alectinib Price in India: Brand, Generic and Monthly Cost
- Alectinib Side Effects: The Complete List and Timeline
- Alectinib Success Rate and Survival: An Honest Look at the Numbers
- Alectinib and Brain Metastases: How It Protects the Brain
- Alectinib in Elderly Patients and Those With Other Illnesses
- Alectinib vs Crizotinib vs Lorlatinib: Choosing an ALK Inhibitor
- Diet and Nutrition While on Alectinib
- Do You Need Chemotherapy Alongside Alectinib?
- Drug, Food and Supplement Interactions With Alectinib
- Fertility, Pregnancy and Contraception on Alectinib
- How Does Alectinib Work? The Second-Generation ALK Inhibitor Explained
- How Long Does Alectinib Take to Work?
- How Long Will You Stay on Alectinib?
- Muscle Pain and High CPK on Alectinib: When to Worry
- Severe Sun Sensitivity on Alectinib: Preventing Serious Burns
- Taking Alectinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Alectinib
- Weight Gain, Constipation and a Slow Pulse on Alectinib
- When Alectinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Alectinib? ALK-Positive Lung Cancer
- Will Insurance or a Government Scheme Pay for Alectinib?
- Work, Travel and Daily Life on Alectinib
Drug Deep Dive: Gefitinib (Iressa)
- Diarrhoea on Gefitinib: Home Management and Warning Signs
- Diet and Nutrition While on Gefitinib
- Fertility, Pregnancy and Contraception on Gefitinib
- Gefitinib (Iressa, Geftinat, Geftib): The Complete Patient Guide
- Gefitinib Myths: 'It's Only for Poor Patients' and Other Half-Truths
- Gefitinib Plus Chemotherapy: Does Adding Chemo Actually Help?
- Gefitinib Price in India: Brand, Generic and Monthly Cost
- Gefitinib Rash: Why It Appears in Week Two and How to Treat It
- Gefitinib Side Effects: The Complete List and Timeline
- Gefitinib Success Rate and Survival: An Honest Look at the Numbers
- Gefitinib and Antacids: The Interaction That Silently Reduces Absorption
- Gefitinib in Early-Stage vs Advanced Lung Cancer: Different Goals
- Gefitinib in Elderly Patients and Those With Other Illnesses
- Gefitinib vs Osimertinib: Making the Decision When Cost Matters
- How Does Gefitinib Work? The First-Generation EGFR Inhibitor Explained
- How Long Does Gefitinib Take to Work?
- How Long Will You Stay on Gefitinib?
- Raised Liver Enzymes on Gefitinib: What Your LFT Report Means
- T790M Testing After Gefitinib Stops Working: The Next Step Explained
- Taking Gefitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Gefitinib
- When Gefitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Gefitinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Gefitinib?
- Work, Travel and Daily Life on Gefitinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Will I need an ECG or heart scan before starting osimertinib?
Most oncologists check a baseline ECG before starting, and many also check your heart's pumping function with an echocardiogram or MUGA scan. This baseline matters because it gives your team a starting point to compare against if a question arises later. If you have not been told whether this was done, ask your team before your first dose.
Can I keep taking osimertinib if my heart is affected?
In many cases, yes — at least initially. Mild changes are often managed with closer monitoring while treatment continues. More significant changes may lead your oncologist to pause the dose temporarily or reduce it, and in a small number of cases treatment may need to stop. The decision depends on how well your cancer is responding and how much the heart has been affected. Reporting symptoms early is what keeps the milder options available.
Which medicines should I avoid on osimertinib?
Several medicines — including some antibiotics, antifungals, heart drugs and even some antihistamines — can additionally prolong the heart's electrical interval in a way that adds to osimertinib's effect. Rather than memorising a list, the practical rule is simple: tell your oncology team before starting anything new, including tablets bought over the counter or from a pharmacy without a prescription. They will check the interaction for you.
Is new breathlessness always a heart problem on osimertinib?
No. Breathlessness has several causes in people taking osimertinib. Fluid collecting around the lung — a pleural effusion — is a known side effect of the drug and is not a heart problem. The underlying lung cancer can also cause breathlessness. Your team needs to examine you and may need a scan to tell the causes apart. Report any new or worsening breathlessness the same day rather than waiting for your next scheduled visit.
How often will my heart be checked during treatment?
Your team will set a monitoring schedule based on your individual risk and how you respond to the drug. At minimum, most oncologists repeat the ECG periodically and check symptoms at every visit. If you develop palpitations, breathlessness or other cardiac symptoms, monitoring becomes more frequent. If you are unsure what schedule you are on, ask your team to explain what is planned and when.